Atara Biotherapeutics Statistics
Total Valuation
ATRA has a market cap or net worth of $95.60 million. The enterprise value is $97.33 million.
| Market Cap | 95.60M |
| Enterprise Value | 97.33M |
Important Dates
The next estimated earnings date is Monday, August 10, 2026, after market close.
| Earnings Date | Aug 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ATRA has 9.01 million shares outstanding. The number of shares has increased by 52.43% in one year.
| Current Share Class | 9.01M |
| Shares Outstanding | 9.01M |
| Shares Change (YoY) | +52.43% |
| Shares Change (QoQ) | +3.38% |
| Owned by Insiders (%) | 2.78% |
| Owned by Institutions (%) | 31.23% |
| Float | 4.66M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.13 |
| Forward PS | 62.35 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.21 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.16
| Current Ratio | 2.16 |
| Quick Ratio | 1.48 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -0.70 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -3.83% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -17.51% |
| Weighted Average Cost of Capital (WACC) | 7.07% |
| Revenue Per Employee | $1.78M |
| Profits Per Employee | -$728,231 |
| Employee Count | 13 |
| Asset Turnover | 0.56 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ATRA has paid $31,000 in taxes.
| Income Tax | 31,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +33.63% in the last 52 weeks. The beta is 0.11, so ATRA's price volatility has been lower than the market average.
| Beta (5Y) | 0.11 |
| 52-Week Price Change | +33.63% |
| 50-Day Moving Average | 8.00 |
| 200-Day Moving Average | 9.99 |
| Relative Strength Index (RSI) | 60.95 |
| Average Volume (20 Days) | 103,517 |
Short Selling Information
The latest short interest is 484,391, so 5.38% of the outstanding shares have been sold short.
| Short Interest | 484,391 |
| Short Previous Month | 546,470 |
| Short % of Shares Out | 5.38% |
| Short % of Float | 10.39% |
| Short Ratio (days to cover) | 0.12 |
Income Statement
In the last 12 months, ATRA had revenue of $23.14 million and -$9.47 million in losses. Loss per share was -$0.71.
| Revenue | 23.14M |
| Gross Profit | 16.22M |
| Operating Income | -2.51M |
| Pretax Income | -9.44M |
| Net Income | -9.47M |
| EBITDA | -2.16M |
| EBIT | -2.51M |
| Loss Per Share | -$0.71 |
Balance Sheet
The company has $8.36 million in cash and $10.09 million in debt, with a net cash position of -$1.73 million or -$0.19 per share.
| Cash & Cash Equivalents | 8.36M |
| Total Debt | 10.09M |
| Net Cash | -1.73M |
| Net Cash Per Share | -$0.19 |
| Equity (Book Value) | -37.31M |
| Book Value Per Share | -4.38 |
| Working Capital | 6.53M |
Cash Flow
| Operating Cash Flow | -25.88M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 350,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -25.88M |
| FCF Per Share | -$2.87 |
Margins
Gross margin is 70.11%, with operating and profit margins of -10.86% and -40.91%.
| Gross Margin | 70.11% |
| Operating Margin | -10.86% |
| Pretax Margin | -40.78% |
| Profit Margin | -40.91% |
| EBITDA Margin | -9.35% |
| EBIT Margin | -10.86% |
| FCF Margin | n/a |
Dividends & Yields
ATRA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -52.43% |
| Shareholder Yield | n/a |
| Earnings Yield | -9.90% |
| FCF Yield | -27.07% |
Analyst Forecast
The average price target for ATRA is $13.67, which is 28.84% higher than the current price. The consensus rating is "Buy".
| Price Target | $13.67 |
| Price Target Difference | 28.84% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | -32.10% |
| EPS Growth Forecast (3Y) | -32.61% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 20, 2024. It was a reverse split with a ratio of 1:25.
| Last Split Date | Jun 20, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
ATRA has an Altman Z-Score of -139.98 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -139.98 |
| Piotroski F-Score | 2 |